SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. SU5416 may stop the growth of solid tumors by stopping blood flow
to the tumor. Combining more than once chemotherapy drug with SU5416 may kill more tumor
cells.
PURPOSE: Phase I trial to study the effectiveness of SU5416 combined with gemcitabine and
cisplatin in treating patients who have advanced solid tumors.